Shareholder Information

Shareholder Meeting Notices

Date Title Document Webcast
28/09/2018 Shareholder Circular and Notice of General Meeting to be held on 15 October 2018
13/08/2018 Notice of 2018 AGM
28/09/2017 Notice of General Meeting to be held on 16 October 2017
11/04/2017 Notice of Annual General Meeting 2017
12/10/2016 Notice of General Meeting to be held on 28 October 2016
11/05/2016 Notice of 2016 AGM
21/05/2015 Notice of 2015 AGM
Share Detail
Number of shares 61,184,135
Country of listing UK / US
Status AIM Listed / NASDAQ Listed
Index FTSE AIM All Share / NASDAQ
FTSE Sector Pharmaceutical & Biotechnology
FTSE sub-sector Biotechnology
Ticker MTPH / MTP

The percentage of 0.005p Ordinary shares not being held in public hands is 80.9%

Shares held in treasury: Nil 0.005p Ordinary shares.

There are no restrictions on the transfer of Ordinary shares in the Company.

Information correct as at 14 September 2018.

Major Shareholders

Midatech Pharma has been notified or is aware of the following holdings of more than 3% or more of the issued share capital of the Company.

Name Number of shares %
Woodford Investment Management 12,247,629 20.0
Legal & General Group 9,373,017 15.3
City Financial 3,125,000 5.1
Wings Establishment 3,043,164 5.0
Hargreaves Lansdowne 1,930,697 3.2
Midatech Pharma Share Incentive Plan 207,158 n/a

Information correct as at 14 September 2018

ADR Information
Ticker Structure Exchange Ratio DR ISIN CUSIP
MTP Level III ADR NASDAQ 1 ADR : 2 Ordinary Shares US59564R1041 59564R104